JP2009532372A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009532372A5 JP2009532372A5 JP2009503119A JP2009503119A JP2009532372A5 JP 2009532372 A5 JP2009532372 A5 JP 2009532372A5 JP 2009503119 A JP2009503119 A JP 2009503119A JP 2009503119 A JP2009503119 A JP 2009503119A JP 2009532372 A5 JP2009532372 A5 JP 2009532372A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- agent according
- hydrogen
- agent
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74402106P | 2006-03-31 | 2006-03-31 | |
| PCT/US2007/063288 WO2007117791A2 (en) | 2006-03-31 | 2007-03-05 | Combination treatment of metabolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009532372A JP2009532372A (ja) | 2009-09-10 |
| JP2009532372A5 true JP2009532372A5 (enExample) | 2010-04-22 |
Family
ID=38581719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009503119A Pending JP2009532372A (ja) | 2006-03-31 | 2007-03-05 | 代謝障害の併用治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8338480B2 (enExample) |
| EP (1) | EP2001461A4 (enExample) |
| JP (1) | JP2009532372A (enExample) |
| KR (1) | KR20080106455A (enExample) |
| CN (1) | CN101410105A (enExample) |
| AU (1) | AU2007235145B2 (enExample) |
| CA (1) | CA2647258A1 (enExample) |
| IL (1) | IL194189A0 (enExample) |
| MX (1) | MX2008012506A (enExample) |
| NZ (1) | NZ571118A (enExample) |
| WO (1) | WO2007117791A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2341513C2 (ru) * | 2001-06-12 | 2008-12-20 | Веллстат Терапьютикс Корпорейшн | Соединения для лечения метаболических заболеваний |
| WO2006127133A2 (en) | 2005-04-01 | 2006-11-30 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| JP2009525982A (ja) * | 2006-02-02 | 2009-07-16 | ウェルスタット セラピューティクス コーポレイション | 代謝障害の治療のための化合物 |
| MX2010002562A (es) * | 2007-09-07 | 2011-04-11 | Inst Nac De Ciencias Medicas Y Nutricion | Uso de los niveles de antigeno secretor, de lewis y de sialilo como predictores para enfermedad. |
| WO2009091732A1 (en) * | 2008-01-15 | 2009-07-23 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| EP2085120A1 (en) * | 2008-02-01 | 2009-08-05 | Merz Pharma GmbH & Co. KGaA | The use of substances for the treatment of central or peripheral insulin receptor impairment and insulin resistance |
| US8829058B2 (en) * | 2008-03-13 | 2014-09-09 | Wellstat Therapeutics Corporation | Compounds and method for reducing uric acid |
| JP2012532195A (ja) | 2009-07-06 | 2012-12-13 | チルドレンズ ホスピタル メディカル センター | 乳オリゴ糖による炎症の阻害 |
| US20130331452A1 (en) | 2010-09-08 | 2013-12-12 | Wellstat Therapeutics Corporation | Benzoic acid compounds for reducing uric acid |
| US9805725B2 (en) | 2012-12-21 | 2017-10-31 | Dolby Laboratories Licensing Corporation | Object clustering for rendering object-based audio content based on perceptual criteria |
| US10626460B2 (en) | 2013-02-21 | 2020-04-21 | Children's Hospital Medical Center | Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease |
| JP6660668B2 (ja) * | 2014-06-24 | 2020-03-11 | 花王株式会社 | Ｕｃｐ−１発現促進剤 |
| US10758519B2 (en) | 2014-06-24 | 2020-09-01 | Kao Corporation | UCP-1 expression promoter |
| WO2015199097A1 (ja) * | 2014-06-24 | 2015-12-30 | 花王株式会社 | Ｕｃｐ－１発現促進剤 |
| JP6553375B2 (ja) * | 2014-06-24 | 2019-07-31 | 花王株式会社 | Ｕｃｐ−１発現促進剤 |
| US10857167B2 (en) | 2015-04-28 | 2020-12-08 | Children's Hospital Medical Center | Use of oligosaccharide compositions to enhance weight gain |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE186724T1 (de) * | 1987-09-04 | 1999-12-15 | Beecham Group Plc | Substituierte thiazolidindionderivate |
| TW438587B (en) * | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| US6472373B1 (en) * | 1997-09-21 | 2002-10-29 | Schering Corporation | Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection |
| US6172046B1 (en) * | 1997-09-21 | 2001-01-09 | Schering Corporation | Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection |
| CN1543451A (zh) * | 2001-06-07 | 2004-11-03 | 过氧化物酶体增生剂激活的受体的调节剂 | |
| RU2341513C2 (ru) * | 2001-06-12 | 2008-12-20 | Веллстат Терапьютикс Корпорейшн | Соединения для лечения метаболических заболеваний |
| CA2502297C (en) * | 2002-11-01 | 2011-12-13 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| ES2530235T3 (es) * | 2003-02-13 | 2015-02-27 | Wellstat Therapeutics Corporation | Compuestos para el tratamiento de trastornos metabólicos |
| ES2353601T3 (es) * | 2003-04-15 | 2011-03-03 | Wellstat Therapeutics Corporation | Compuestos para el tratamiento de trastornos metabólicos. |
| CN1777576A (zh) * | 2003-04-22 | 2006-05-24 | 维尔斯达医疗公司 | 用于治疗代谢紊乱的化合物 |
| CA2522738C (en) * | 2003-04-30 | 2011-11-08 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| MXPA06001963A (es) * | 2003-08-20 | 2006-05-31 | Wellstat Therapeutics Corp | Compuestos para el tratamiento de trastornos metabolicos. |
| WO2006127133A2 (en) | 2005-04-01 | 2006-11-30 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| FR2887881B1 (fr) | 2005-07-01 | 2009-10-09 | Pierre Fabre Medicament Sa | Inhibiteurs de proteines kinases |
| US7820721B2 (en) * | 2006-01-25 | 2010-10-26 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| AU2007208127A1 (en) * | 2006-01-25 | 2007-08-02 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
-
2007
- 2007-03-05 WO PCT/US2007/063288 patent/WO2007117791A2/en not_active Ceased
- 2007-03-05 JP JP2009503119A patent/JP2009532372A/ja active Pending
- 2007-03-05 EP EP07757896A patent/EP2001461A4/en not_active Withdrawn
- 2007-03-05 KR KR1020087023632A patent/KR20080106455A/ko not_active Ceased
- 2007-03-05 AU AU2007235145A patent/AU2007235145B2/en not_active Ceased
- 2007-03-05 MX MX2008012506A patent/MX2008012506A/es not_active Application Discontinuation
- 2007-03-05 CN CNA2007800110442A patent/CN101410105A/zh active Pending
- 2007-03-05 NZ NZ571118A patent/NZ571118A/en not_active IP Right Cessation
- 2007-03-05 CA CA002647258A patent/CA2647258A1/en not_active Abandoned
- 2007-03-05 US US12/294,530 patent/US8338480B2/en not_active Expired - Fee Related
-
2008
- 2008-09-17 IL IL194189A patent/IL194189A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2522291T3 (es) | Agente activador para el receptor activado por el proliferador de peroxisomas | |
| JP2022096662A5 (enExample) | ||
| JP2010501010A5 (enExample) | ||
| JP2004529174A5 (enExample) | ||
| AU2007235145B2 (en) | Combination treatment of metabolic disorders | |
| US8022063B2 (en) | CRTH2 receptor ligands for medicinal uses | |
| JP2023156479A5 (enExample) | ||
| JP2009531280A5 (enExample) | ||
| JP2013519680A5 (enExample) | ||
| JP2010506825A5 (enExample) | ||
| JP2009528375A5 (enExample) | ||
| HRP20140335T1 (hr) | Derivati amino-piridina kao agonisti s1p1/edg1-receptora | |
| JP2009528275A5 (enExample) | ||
| JP2007511485A5 (enExample) | ||
| JP2010539152A5 (enExample) | ||
| RU2006142746A (ru) | Индолилпроизводные в качестве модуляторов печеночного х-рецептора | |
| JP2019517455A5 (enExample) | ||
| CN1503786A (zh) | 高传导率钙-活化k通道开启剂 | |
| JP2004509084A5 (enExample) | ||
| JP2010513397A5 (enExample) | ||
| CA2513092A1 (en) | Compounds for the treatment of metabolic disorders | |
| CN1703407A (zh) | 脂肪酸酰胺水解酶抑制剂 | |
| HRP20160450T1 (hr) | Novi inhibitori reduktaze s-nitrozoglutationa | |
| TW400330B (en) | Novel thiazolidine-2, 4-dione, substitute, the manufacture method and the pharmaceutical compositions therefof | |
| JP2009544721A5 (enExample) |